Next-gen Biomanufacturing Market
Next-gen Biomanufacturing Market - Global Industry Assessment & Forecast
#
Pages:
190
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2514
Segments Covered
By
Workflow Type Continuous Upstream Biomanufacturing Workflow, Single-Use Upstream Biomanufacturing Workflow, Downstream Biomanufacturing Workflow
-
By
Application Monoclonal Antibodies, Vaccines, Hormones, Recombinant Proteins, Other Applications
-
By
End User Biopharmaceutical Companies, Research Institutions, CMOs/CDMOs
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 20.5 Billion |
 Revenue 2032:
|
USD 39.4 Billion |
 Revenue CAGR
(2024 - 2032): |
7.5% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Next-gen Biomanufacturing Market Segment Analysis
- Next-gen Biomanufacturing Workflow Type Outlook (Revenue, USD Million, 2018 - 2030)
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Next-gen Biomanufacturing Application Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Next-gen Biomanufacturing End User Outlook (Revenue, USD Million, 2018 - 2030)
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
-
North America Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
-
North America Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- U.S.
- U.S. Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- U.S. Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- U.S. Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- U.S. Next-gen Biomanufacturing Market, by Workflow Type
- Canada
- Canada Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Canada Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Canada Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Canada Next-gen Biomanufacturing Market, by Workflow Type
-
Mexico
- Mexico Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Mexico Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Mexico Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Mexico Next-gen Biomanufacturing Market, by Workflow Type
-
North America Next-gen Biomanufacturing Market, by Workflow Type
- Europe
-
Europe Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
-
Europe Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
-
Europe Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- U. K.
- U.K. Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- U.K. Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- U.K. Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- U.K. Next-gen Biomanufacturing Market, by Workflow Type
- France
- France Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- France Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- France Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- France Next-gen Biomanufacturing Market, by Workflow Type
-
Germany
- Germany Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Germany Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Germany Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Germany Next-gen Biomanufacturing Market, by Workflow Type
-
Italy
- Italy Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Italy Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Italy Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Italy Next-gen Biomanufacturing Market, by Workflow Type
-
Spain
- Spain Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Spain Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Spain Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Spain Next-gen Biomanufacturing Market, by Workflow Type
-
Rest of Europe
- Rest of Europe Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Rest of Europe Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Rest of Europe Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Rest of Europe Next-gen Biomanufacturing Market, by Workflow Type
-
Europe Next-gen Biomanufacturing Market, by Workflow Type
- Asia Pacific
-
Asia Pacific Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
-
Asia Pacific Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
-
Asia Pacific Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- China
- China Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- China Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- China Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- China Next-gen Biomanufacturing Market, by Workflow Type
- Japan
- Japan Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Japan Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Japan Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Japan Next-gen Biomanufacturing Market, by Workflow Type
-
Germany
- Germany Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Germany Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Germany Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Germany Next-gen Biomanufacturing Market, by Workflow Type
-
India
- India Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- India Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- India Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- India Next-gen Biomanufacturing Market, by Workflow Type
-
South Korea
- South Korea Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- South Korea Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- South Korea Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- South Korea Next-gen Biomanufacturing Market, by Workflow Type
-
South East Asia
- South East Asia Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- South East Asia Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- South East Asia Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- South East Asia Next-gen Biomanufacturing Market, by Workflow Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Rest of Asia Pacific Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Rest of Asia Pacific Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Rest of Asia Pacific Next-gen Biomanufacturing Market, by Workflow Type
-
Asia Pacific Next-gen Biomanufacturing Market, by Workflow Type
- Latin America
-
Latin America Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
-
Latin America Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
-
Latin America Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Brazil
- Brazil Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Brazil Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Brazil Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Brazil Next-gen Biomanufacturing Market, by Workflow Type
- Argentina
- Argentina Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Argentina Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Argentina Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Argentina Next-gen Biomanufacturing Market, by Workflow Type
-
Rest of Latin America
- Rest of Latin America Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Rest of Latin America Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Rest of Latin America Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Rest of Latin America Next-gen Biomanufacturing Market, by Workflow Type
-
Latin America Next-gen Biomanufacturing Market, by Workflow Type
- Middle East & Africa
-
Middle East & Africa Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
-
Middle East & Africa Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
-
Middle East & Africa Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- GCC Countries
- GCC Countries Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- GCC Countries Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- GCC Countries Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- GCC Countries Next-gen Biomanufacturing Market, by Workflow Type
- South Africa
- South Africa Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- South Africa Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- South Africa Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- South Africa Next-gen Biomanufacturing Market, by Workflow Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Next-gen Biomanufacturing Market, by Workflow Type
- Continuous Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufacturing Workflow
- Downstream Biomanufacturing Workflow
- Rest of Middle East & Africa Next-gen Biomanufacturing Market, by Application
- Monoclonal Antibodies
- Vaccines
- Hormones
- Recombinant Proteins
- Other Applications
- Rest of Middle East & Africa Next-gen Biomanufacturing Market, by End User
- Biopharmaceutical Companies
- Research Institutions
- CMOs/CDMOs
- Rest of Middle East & Africa Next-gen Biomanufacturing Market, by Workflow Type
-
Middle East & Africa Next-gen Biomanufacturing Market, by Workflow Type
- North America
Vantage Market
Research | 24-Jun-2024
FAQ
Frequently Asked Question
What is the global demand for Next-gen Biomanufacturing in terms of revenue?
-
The global Next-gen Biomanufacturing valued at USD 20.5 Billion in 2023 and is expected to reach USD 39.4 Billion in 2032 growing at a CAGR of 7.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Merck KGaA (Germany), Danaher Corp. (U.S.), Sartorius AG (Germany), Applikon Biotechnology B.V. (Netherlands), Getinge AB (Sweden), Thermo Fisher Scientific Inc. (U.S.), PBS Biotech Inc. (U.S.), bbi-biotech GmbH (Germany), Solaris Biotechnology (Italy), Meissner Corp. (U.S.), ESCO Group LLC (U.S.), GEA Group (Germany).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.5% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Next-gen Biomanufacturing include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Next-gen Biomanufacturing in 2023.
